« Back
Home /
Tanespimycin (17-AAG)

Tanespimycin (17-AAG)

Item no.	S1141-5
Manufacturer	Selleckchem
CASRN	75747-14-7
Amount	5 mg
Quantity options	100 mg 1 g 10 g 10 mM/1 mL 200 mg 25 mg 5 mg 5 g
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Smiles	CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	CP127374,NSC-330507,KOS 953
Available
Manufacturer - Targets	HSP (HSP90)
Storage Conditions	2 years -80 in solvent
Information	Tanespimycin (17-AAG, CP127374, NSC-330507, KOS 953) is a potent HSP90 inhibitor with IC50 of 5 nM in a cell-free assay, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells. Tanespimycin (17-AAG) induces apoptosis, necrosis, autophagy and mitophagy. Phase 3.
Pathway	Cytoskeletal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

S1141-5-datasheet.pdf

S1141-5-safety-datasheet.pdf